SUDAFED

This brand name is authorized in Canada, Cyprus, Estonia, Lithuania, Malta, Poland, Turkey, United Kingdom, South Africa

Active ingredients

The drug SUDAFED contains one active pharmaceutical ingredient (API):

1 Pseudoephedrine UNII 6V9V2RYJ8N - PSEUDOEPHEDRINE HYDROCHLORIDE

Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion. Read about Pseudoephedrine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SUDAFED NOSE SPRAY Aqueous solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AE51	Ibuprofen, combinations	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02242217
Country: EE	Ravimiamet	Identifier(s): 1006401, 1006669, 1770050
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 24377, 24383
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006810
Country: MT	Medicines Authority	Identifier(s): AA908/09901
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100098533, 100276762
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522015269, 8699522571253
Country: ZA	Health Products Regulatory Authority	Identifier(s): F/5.8/82